30-day FRN

Federal Register / Vol. 83, No. 199 / Monday, October 15, 2018 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cardiovascular Sciences.
Date: November 8–9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Alexandria Old
Town, 1900 Diagonal Road, Alexandria, VA
22314.
Contact Person: Margaret Chandler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4126,
MSC 7814, Bethesda, MD 20892, (301) 435–
1743, margaret.chandler@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Myalgic
Encephalomyelitis/Chronic Fatigue
Syndrome.
Date: November 8, 2018.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jana Drgonova, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213,
Bethesda, MD 20892, 301–827–2549,
jdrgonova@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Prevention.
Date: November 8, 2018.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Syed M. Quadri, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6210,
MSC 7804, Bethesda, MD 20892, 301–435–
1211, quadris@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 9, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–22318 Filed 10–12–18; 8:45 am]
khammond on DSK30JT082PROD with NOTICES

BILLING CODE 4140–01–P

VerDate Sep<11>2014

21:34 Oct 12, 2018

Jkt 247001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Intramural
Continuing Umbrella of Research
Experiences (iCURE) Application—
National Cancer Institute
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, should be
directed to the: Office of Management
and Budget, Office of Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: Desk
Officer for NIH.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Alison Lin, 9609
Medical Center Drive, Rockville, MD
20850 or call non-toll-free number (240)
276–6177 or Email your request,
including your address to: linaj@
mail.nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on July 27, 2018, page 35665
(83 FR 35665) and allowed 60 days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment.
The National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
SUMMARY:

PO 00000

Frm 00043

Fmt 4703

Sfmt 4703

51965

extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Intramural
Continuing Umbrella of Research
Experiences (iCURE) Application, 0925–
XXXX, Exp., Date XX/XXXX, EXISTING
COLLECTION IN USE WITHOUT OMB
NUMBER, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The new Intramural
Continuing Umbrella of Research
Experiences (iCURE) program supports
mentored research experiences for
qualified post-baccalaureate (including
post masters) individuals, graduate
students, and postdoctoral fellows in
the multidisciplinary National Cancer
Institute (NCI) intramural research
environment. This information
collection request are applications and a
reference letter to help evaluate the
merits of the candidates and their
potential match for the iCURE program.
iCURE is an extension of the highly
successful NCI Center to Reduce Cancer
Health Disparities’ (CRCHD) Continuing
Umbrella of Research Experiences
(CURE) program which helps support
the career progress of its scholars
toward research independence, as well
as fosters and sustains diversity in the
biomedical research pipeline. Like the
CURE program, iCURE strongly
encourages the participation of
individuals from underrepresented
populations and is aligned with NCI’s
interest in diversity. The benefit of
collecting this information is to enable
the selection of the best matching
candidates for the iCURE program. The
iCURE program aims to, 1. Enhance the
diversity of the NCI Intramural Research
Program (IRP), and 2. Promote the career
progress of the iCURE scholars in cancer
research.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated burden hours are 305.

E:\FR\FM\15OCN1.SGM

15OCN1

51966

Federal Register / Vol. 83, No. 199 / Monday, October 15, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS

Post-Baccalaureate
Supplemental
Application.
Graduate Student Application ...........
Postdoctoral Fellowship Application
Reference Letter ...............................

Post-Baccalaureate (Including PostMaster’s) Individuals.
Graduate Students ...........................
Postdoctoral Candidates ..................
PIs, professors, supervisors .............

50

1

30/60

25

30
50
240

1
1
1

2
2
30/60

60
100
120

Totals .........................................

...........................................................

370

370

........................

305

Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 5, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.

[FR Doc. 2018–22319 Filed 10–12–18; 8:45 am]
BILLING CODE 4140–01–P

[FR Doc. 2018–22311 Filed 10–12–18; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

khammond on DSK30JT082PROD with NOTICES

Average
time per
response
(in hours)

Type of
respondent

Dated: October 2, 2018.
Patricia M. Busche,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.

Number of
respondents

Number of
responses
per
respondent

Form name

Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Genomic Centers for
Infectious Diseases (U19 Clinical Trial Not
Allowed).
Date: November 8–9, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Eleazar Cohen, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G62A, National Institute of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20899823, (240) 669–5081,
ecohen@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,

VerDate Sep<11>2014

21:34 Oct 12, 2018

Jkt 247001

National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: November 5, 2018.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Lee G. Klinkenberg, Ph.D.,
Scientific Review Program, DEA/NIAID/NIH/
DHHS, 5601 Fishers Lane, MSC–9823,
Bethesda, MD 20892–9834, 301–761–7749,
lee.klinkenberg@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Sexually Transmitted
Infections CRC: Vaccine Development (U19).
Date: November 8–9, 2018.

PO 00000

Frm 00044

Fmt 4703

Sfmt 4703

Total annual
burden hour

Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Annie Walker-Abbey,
Ph.D., Scientific Review Officer, Scientific
Review Program, AID/NIH/DHHS, 5601
Fishers Lane, Room 3E70A, Rockville, MD
20852, 240–627–3390, aabbey@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 5, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–22312 Filed 10–12–18; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIH
Pathway to Independence Award (K99/R00).
Date: October 17, 2018.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.

E:\FR\FM\15OCN1.SGM

15OCN1